Background Cytokines and chemokines are relevant biomarkers of pathology and immunity to infectious diseases such as malaria. Several commercially available kits based on quantitative suspension array technologies allow the profiling of multiple cytokines and chemokines in small volumes of sample. However, kits are being continuously improved and information on their performance is lacking. Methodology/Principal Findings Different cytokine/chemokine kits, two flow cytometry-based (eBioscience？ FlowCytomix？ and BD？ Cytometric Bead Array Human Enhanced Sensitivity) and four Luminex？-based (Invitrogen？ Human Cytokine 25-Plex Panel, Invitrogen？ Human Cytokine Magnetic 30-Plex Panel, Bio-Rad？ Bio-Plex Pro？ Human Cytokine Plex Assay and Millipore？ MILLIPLEX？ MAP Plex Kit) were compared. Samples tested were supernatants of peripheral blood mononuclear cells of malaria-exposed children stimulated with Plasmodium falciparum parasite lysates. Number of responses in range that could be detected was determined and reproducibility of duplicates was evaluated by the Bland-Altman test. Luminex？ kits performed better than flow cytometry kits in number of responses in range and reproducibility. Luminex？ kits were more reproducible when magnetic beads were used. However, within each methodology overall performance depended on the analyte tested in each kit. Within the Luminex？ kits, the Invitrogen？ with polystyrene beads had the poorer performance, whereas Invitrogen？ with magnetic beads had the higher percentage of cytokines/chemokines with both readings in range (40%), followed by Bio-Rad？ with magnetic beads (35%). Regarding reproducibility, the Millipore？ kit had the highest percentage (60%) of cytokines/chemokines with acceptable limits of agreement (<30%), followed by the Invitrogen？ with magnetic beads (40%) that had tighter limits of agreement. Conclusions/Significance Currently available kits for cytokine and chemokine quantification differ in reproducibility and concentration range of accurate detection. Luminex？-based kits with magnetic beads perform the best. Data highlights the importance of testing different kits before each study to choose the most appropriate, depending on the priority of the cytokines assessed.
References
[1]
Seder RA, Darrah PA, Roederer M (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Immunol 8: 247–258.
[2]
Doba？o C, Campo JJ (2009) Understanding protective immune mechanisms induced by malaria vaccines in the context of clinical trials. Hum Vaccin 5: 562–565.
[3]
Langhorne J, Ndungu FM, Sponaas A-M, Marsh K (2008) Immunity to malaria: more questions than answers. Nat Immunol 9: 725–732.
[4]
Sun Y, Jin C, Zhan F, Wang X, Liang M, et al. (2012) Host Cytokine Storm Is Associated With Disease Severity of Severe Fever With Thrombocytopenia Syndrome. J Infect Dis 206: 1085–1094.
[5]
Prakash D, Fesel C, Jain R, Cazenave P-A, Mishra GC, et al. (2006) Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India. J Infect Dis 194: 198–207.
[6]
Jost S, Quillay H, Reardon J, Peterson E, Simmons RP, et al. (2011) Changes in cytokine levels and NK cell activation associated with influenza. PloS ONE 6: e25060.
[7]
Stacey AR, Norris PJ, Qin L, Haygreen E a, Taylor E, et al. (2009) Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83: 3719–3733.
[8]
To KKW, Hung IFN, Li IWS, Lee K-L, Koo C-K, et al. (2010) Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50: 850–859.
[9]
Rovira-Vallbona E, Moncunill G, Bassat Q, Aguilar R, Machevo S, et al. (2012) Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: a case-control study. Malar J 11: 181.
[10]
Richens JL, Urbanowicz RA, Metcalf R, Corne J, O’Shea P, et al. (2010) Quantitative validation and comparison of multiplex cytokine kits. J Biomol Screen 15: 562–568.
[11]
Djoba Siawaya JF, Roberts T, Babb C, Black G, Golakai HJ, et al. (2008) An evaluation of commercial fluorescent bead-based luminex cytokine assays. PloS ONE 3: e2535.
[12]
Nechansky A, Grunt S, Roitt IM, Kircheis R (2008) Comparison of the Calibration Standards of Three Commercially Available Multiplex Kits for Human Cytokine Measurement to WHO Standards Reveals Striking Differences. Biomark Insights 3: 227–235.
[13]
Young S-H, Antonini JM, Roberts JR, Erdely AD, Zeidler-Erdely PC (2008) Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent models. J Immunol Methods 331: 59–68.
[14]
Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP (2004) Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 61: 35–39 doi:10.1002/cyto.b.20021.
[15]
Berthoud TK, Manaca MN, Quelhas D, Aguilar R, Guinovart C, et al. (2011) Comparison of commercial kits to measure cytokine responses to Plasmodium falciparum by multiplex microsphere suspension array technology. Malar J 10: 115.
[16]
Khan IH, Krishnan VV, Ziman M, Janatpour K, Wun T, et al. (2009) A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry B Clin Cytom 76: 159–168.
[17]
Defawe OD, Fong Y, Vasilyeva E, Pickett M, Carter DK, et al. (2012) Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells. J Immunol Methods 382: 117–128.
[18]
Guinovart C, Doba？o C, Bassat Q, Nhabomba A, Quintó L, et al. (2012) The Role of Age and Exposure to Plasmodium falciparum in the Rate of Acquisition of Naturally Acquired Immunity: A Randomized Controlled Trial. PloS ONE 7: e32362.
[19]
Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307–310.
[20]
Carstensen B, Gurrin L, Ekstrom C (2012) MethComp: Functions for analysis of method comparison studies. Available:R package version 1.15. http://CRAN.R-project.org/package=MethCo？mp.
[21]
Development Core Team (2005) R A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3–900051–07–0. Available: http://www.r-project.org. Accessed: 6 September 2012.
[22]
Barbosa A, Naniche D, Aponte JJ, Manaca MN, Mandomando I, et al. (2009) Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique. Infect Immun 77: 4502–4509.
[23]
Kellar KL, Kalwar RR, Dubois K a, Crouse D, Chafin WD, et al. (2001) Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 45: 27–36.
